Inspire Medical Systems, Inc.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Timothy P. Herbert
- Full Time Employees
- 1,333
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- 5500 Wayzata Boulevard Golden Valley MN United States 55416
- IPO Date
- May 3, 2018
- CIK
- 0001609550
- Website
- inspiresleep.com
- Similar Companies
- Business
- Inspire Medical Systems, Inc. (NYSE: INSP) develops and commercializes the Inspire therapy, an implantable neurostimulation system designed to treat moderate to severe obstructive sleep apnea (OSA) in adult patients unable to use or get consistent benefit from continuous positive airway pressure (CPAP) devices. The company's core products and services include the Inspire Upper Airway Stimulation (UAS) system, consisting of the Inspire implantable pulse generator (IPG), stimulation lead, sensing lead, and external patient remote control; surgical tools and accessories for implantation; the myInspire patient management platform for remote monitoring and therapy adjustments; and physician and patient education programs supporting therapy adoption. Inspire therapy offers a masked volume reduction alternative to CPAP, with implantation performed by ENTs and sleep surgeons in outpatient procedures; the company provides direct-to-consumer marketing, reimbursement support services, and post-market clinical research through its registry studies. Founded in 2007 and headquartered in Golden Valley, Minnesota, Inspire Medical Systems operates primarily in the United States, with expanding commercial presence in Europe (including select countries via partnerships) and international markets targeting adult OSA patients underserved by traditional therapies. The company serves sleep clinics, ENT practices, hospitals, and sleep surgeons as key customers, focusing on the medical device segment of the sleep health industry valued at billions annually. In recent developments, Inspire Medical Systems reported strong revenue growth in 2025, driven by increased procedure volumes and market adoption; the company expanded its European operations through new regulatory approvals and partnerships in 2024-2025. It launched enhancements to the Inspire therapy platform, including software updates for improved therapy titration and remote monitoring capabilities; additionally, Inspire announced positive results from ongoing post-market studies demonstrating long-term efficacy and safety, supporting expanded indications. No major acquisitions, funding rounds, or name changes were reported in the last 1-2 years, with strategic focus remaining on U.S. market penetration and international scaling.
Company News
Inspire Medical Systems: The Moat Just Passed Its Worst-Case Stress Test
Inspire Medical Systems, Inc. to Present at the Stifel 2026 Healthcare Conference
These Analysts Increase Their Forecasts On Inspire Medical After Strong Q3 Results
Inspire Medical Systems, Inc. (INSP) Q3 2026 Earnings Call Transcript
Inspire Medical Systems Q3 Earnings Call Highlights
Inspire Medical Systems (INSP) Q3 Earnings and Revenues Beat Estimates
Here's What Key Metrics Tell Us About Inspire (INSP) Q3 Earnings
Inspire Medical Systems, Inc. Announces Third Quarter 2026 Financial Results
INSP Stock Gains 47.8% in Three Months: What's Driving the Rally?
Inspire Medical Systems Inc (INSP) Stock Up 3.3% and Still Undervalued -- GF Score: 64/100
Roche Diagnostics delivers laboratory equipment to support Ebola testing in DRC
Inspire Medical Systems, Inc. to Report Third Quarter 2026 Financial Results on November 2, 2026
Inspire Medical Gains New CPT Codes for Hypoglossal Nerve Stimulation
Inspire Medical Systems, Inc. Announces Approval of New Hypoglossal Nerve Stimulation CPT® Codes by the AMA Editorial Panel
Here's Why You Should Retain INSP Stock in Your Portfolio for Now
Is It Too Late to Buy Inspire Medical Systems Inc (INSP) After 5.5% Rally? GF Value Says Undervalued
Hsbc Holdings PLC Has $274,000 Stock Holdings in Inspire Medical Systems, Inc. $INSP
Zacks Industry Outlook Medical Systems, American Well and Butterfly Network
3 Medical Info Systems Stocks to Gain From GenAI Boom Amid Cyber Risk
Bank of New York Mellon Corp Makes New $6.63 Million Investment in Inspire Medical Systems, Inc. $INSP